Rapid Diagnosis of Myocardial Damage and Coronary Stenosis With Magnetic Resonance Imaging (MRI)

The hypothesis is that single-shot imaging of myocardial infarction is possible in atrial fibrillation using MRI late enhancement technique

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Myocardial Infarction Arrhythmias, Cardiac Atrial Fibrillation Cardiovascular Diseases Heart Diseases Infarction Ischemia Myocardial Ischemia Necrosis Pathologic Processes Pathological Conditions, Signs and Symptoms Vascular Diseases

Age range

20 year–80 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Varnamo Hospital

Värnamo, SE33185, Sweden

About this study

50 outpatients in Jonkoping County with a diagnosis of in-hospital myocardial infarction, are asked to participate in this study comparing segmented true FISP late enhancement with single-shot trueFISP late enhancement for the diagnosis of myocardial damage. The study does not intervene regarding treatment but is a comparison of the diagnostic power of the two MRI techniques.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

in-hospital diagnosis of myocardial infarction

Exclusion criteria

pacemaker, not willing to participate, metallic objects in brain or eyes,

Sponsors and collaborators

Lead sponsor

University Hospital, Linkoeping

Other

Collaborators

Jonkoping County Hospital
Medical Research Council of Southeast Sweden

Registry information

Official study title

Rapid Diagnosis of Myocardial Damage and Coronary Stenosis With MRI

Important dates

Study start: 2004
Primary completion: 2005
Study completion: 2009
First posted: Sep 16, 2005
Registry last updated: Jul 15, 2009

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed